TY - JOUR
T1 - Cardiovascular Health in Turner Syndrome
T2 - A Scientific Statement From the American Heart Association
AU - American Heart Association Council on Cardiovascular Disease in the Young; Council on Genomic and Precision Medicine; and Council on Peripheral Vascular Disease
AU - Silberbach, Michael
AU - Roos-Hesselink, Jolien W.
AU - Andersen, Niels H.
AU - Braverman, Alan C.
AU - Brown, Nicole
AU - Collins, R. Thomas
AU - De Backer, Julie
AU - Eagle, Kim A.
AU - Hiratzka, Loren F.
AU - Johnson, Walter H.
AU - Kadian-Dodov, Daniella
AU - Lopez, Leo
AU - Mortensen, Kristian H.
AU - Prakash, Siddharth K.
AU - Ratchford, Elizabeth V.
AU - Saidi, Arwa
AU - van Hagen, Iris
AU - Young, Luciana T.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.
AB - Girls and women with Turner syndrome face a lifelong struggle with both congenital heart disease and acquired cardiovascular conditions. Bicuspid aortic valve is common, and many have left-sided heart obstructive disease of varying severity, from hypoplastic left-sided heart syndrome to minimal aortic stenosis or coarctation of the aorta. Significant enlargement of the thoracic aorta may progress to catastrophic aortic dissection and rupture. It is becoming increasingly apparent that a variety of other cardiovascular conditions, including early-onset hypertension, ischemic heart disease, and stroke, are the major factors reducing the life span of those with Turner syndrome. The presentations and management of cardiovascular conditions in Turner syndrome differ significantly from the general population. Therefore, an international working group reviewed the available evidence regarding the diagnosis and treatment of cardiovascular diseases in Turner syndrome. It is recognized that the suggestions for clinical practice stated here are only the beginning of a process that must also involve the establishment of quality indicators, structures and processes for implementation, and outcome studies.
KW - AHA Scientific Statements
KW - Turner syndrome
KW - aortic aneurysm
KW - genetics
KW - heart diseases
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85055604047&partnerID=8YFLogxK
U2 - 10.1161/HCG.0000000000000048
DO - 10.1161/HCG.0000000000000048
M3 - Review article
C2 - 30354301
AN - SCOPUS:85055604047
SN - 2574-8300
VL - 11
SP - e000048
JO - Circulation. Genomic and precision medicine
JF - Circulation. Genomic and precision medicine
IS - 10
ER -